Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurosci Lett ; 311(2): 77-80, 2001 Sep 28.
Article in English | MEDLINE | ID: mdl-11567782

ABSTRACT

Adenosine 5'-triphosphate (ATP) acts as a neurotransmitter in the central nervous system. Extracellular ATP is also toxic to a number of cell types e.g. via its interaction with P2X membrane receptors, specifically the P2X(7) family member. These results have led to the hypothesis that elevated ATP levels may exacerbate damage during acute neurodegeneration [4]. The aim of this study was to examine the effects of ATP agonists and antagonists on cultured rat cerebellar granule neurones. Neither ATP, nor the P2X agonist benzoylbenzoyl-ATP (BzATP), were toxic when added to primary neurones. However, the P2X(7) antagonist, oxidised ATP (oATP) was highly neurotoxic. This toxicity was inhibited by co-incubation with BzATP. These results demonstrate that oATP is a potent neurotoxin.


Subject(s)
Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/toxicity , Affinity Labels/toxicity , Cerebellum/cytology , Neurons/drug effects , Purinergic P2 Receptor Antagonists , Adenosine Triphosphate/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , In Vitro Techniques , Nerve Degeneration/chemically induced , Neurons/cytology , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2X7
2.
Bioorg Med Chem Lett ; 11(1): 13-6, 2001 Jan 08.
Article in English | MEDLINE | ID: mdl-11140723

ABSTRACT

The synthesis and biological activity of N(epsilon)-Z-[Lys3]didemnin B are reported. This novel analogue retains antiproliferative, cytotoxic, and protein biosynthesis inhibition activities, but at reduced levels. This result suggests the use of [Lys3]didemnin derivatives as potential affinity probes for studying the molecular target(s) of the didemnin class of natural products.


Subject(s)
Affinity Labels/chemical synthesis , Affinity Labels/metabolism , Depsipeptides , Peptides, Cyclic/chemical synthesis , Peptides, Cyclic/metabolism , Affinity Labels/pharmacology , Affinity Labels/toxicity , Cell Division/drug effects , Humans , Inhibitory Concentration 50 , Ligands , Molecular Structure , Peptides, Cyclic/pharmacology , Peptides, Cyclic/toxicity , Protein Biosynthesis , Tumor Cells, Cultured
3.
J Med Chem ; 40(14): 2217-27, 1997 Jul 04.
Article in English | MEDLINE | ID: mdl-9216841

ABSTRACT

With the aim of developing a new series of steroidal affinity labels of the estrogen receptor, six electrophilic 11 beta-ethyl (C2), 11 beta-butyl (C4), or 11 beta-decyl (C10) derivatives of estradiol bearing an 11 beta-terminal electrophilic functionality, i.e. bromine (C4), (methylsulfonyl)oxy (C2 and C4), bromoacetamido (C2 and C4), and (p-tolylsulfonyl)oxy (C10), were synthesized. The range of their affinity constants for binding the estrogen receptor was 0.4-37% that of estradiol; the order of increasing affinity (i) relative to the 11 beta-alkyl arm was ethyl < butyl and (ii) relative to the electrophilic functionality was bromoacetamido < bromine < (methylsulfonyl)oxy. Regardless of the conditions used, including prolonged exposure of the receptor to various pH levels (7-9) and temperatures (0-25 degrees C), the extent of receptor affinity labeling by the 11 beta-ethyl and 11 beta-butyl compounds, if any, was under 10%. This was in sharp contrast to results obtained using 11 beta-((tosyloxy)decyl)estradiol which labeled from 60% to 90% of the receptor hormone-binding sites with an EC50 of approximately 10 nM. Estrogenic and antiestrogenic activities of the compounds were determined using the MVLN cell line, which was established from the estrogen-responsive mammary tumor MCF-7 cells by stable transfection of a recombinant estrogen-responsive luciferase gene. The two 11 beta-ethyl compounds were mainly estrogenic, whereas the three 11 beta-butyl and the 11 beta-decyl compounds essentially showed antiestrogenic activity. The fact that the chemical reactivities of 11 beta-ethyl and 11 beta-butyl compounds were not compromised by interaction with the estrogen receptor made the synthesized high-affinity compounds potential cytotoxic agents which might be able to exert either (i) a specific action on estrogen-regulated genes or (ii) a more general action in estrogen-target cells. Therefore the ability of the compounds (1) to irreversibly abolish estrogen-dependent expression of the luciferase gene and (2) to affect the proliferation of MVLN cells were determined. All electrophiles were able to irreversibly suppress expression of the luciferase gene; the antiestrogenic electrophiles were more potent than the estrogenic ones but less efficient than 4-hydroxytamoxifen, a classical and chemically inert triphenylethylene antiestrogen. Only the antiestrogenic electrophiles decreased cell proliferation; however, they were less potent than 4-hydroxytamoxifen. In conclusion, the synthesized electrophilic estradiol 11 beta-ethyl and 11 beta-butyl derivatives (i) were not efficient affinity labels of the estrogen receptor and (ii) did not display significant cytotoxicity in estrogen-sensitive mammary tumor cells. However, since these derivatives displayed high affinity for the estrogen receptor, they could be used to prepare potential cytotoxic agents which might be selective for tumors affecting estrogen-target tissues, by coupling them with a toxic moiety.


Subject(s)
Affinity Labels/chemical synthesis , Estradiol/analogs & derivatives , Estradiol/chemical synthesis , Estrogen Antagonists/chemical synthesis , Receptors, Estrogen/metabolism , Affinity Labels/chemistry , Affinity Labels/toxicity , Alkylation , Animals , Breast Neoplasms , Cell Survival/drug effects , Clone Cells , Estradiol/chemistry , Estradiol/toxicity , Estrogen Antagonists/chemistry , Estrogen Antagonists/toxicity , Estrogens/pharmacology , Female , Humans , Kinetics , Magnetic Resonance Spectroscopy , Molecular Structure , Recombinant Fusion Proteins/biosynthesis , Structure-Activity Relationship , Transfection , Tumor Cells, Cultured , Vitellogenins/biosynthesis , Xenopus
4.
Life Sci ; 49(26): 2013-21, 1991.
Article in English | MEDLINE | ID: mdl-1749311

ABSTRACT

The carbocyanine dye DiIC18(3) ("DiI") is commonly used for both anterograde and retrograde labeling of neurons, including live neurons in situ and in vitro. In the present experiments, DiIC18(3) was used to label motoneurons in the spinal cords and sensory neurons in the dorsal root ganglia of embryonic rats. When the neurons from these regions were placed in culture, the neurons labeled by the dye were found to die rapidly, suggesting that DiIC18(3) can be toxic to neurons of these types. A related dye, DiIC12(3), was found to be equally suitable for labeling these neurons, and was found not to have detectable toxic effects in vitro.


Subject(s)
Carbocyanines/toxicity , Motor Neurons/drug effects , Neurons, Afferent/drug effects , Affinity Labels/toxicity , Animals , Cell Survival/drug effects , Cells, Cultured , Embryo, Mammalian , Flow Cytometry , Fluorescent Dyes/toxicity , Kinetics , Motor Neurons/cytology , Neurons, Afferent/cytology , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...